994
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Different misfolding mechanisms converge on common conformational changes

Human prion protein pathogenic mutants Y218N and E196K

&
Pages 125-135 | Received 14 Nov 2013, Accepted 10 Jan 2014, Published online: 07 Feb 2014

References

  • Wadsworth JDF, Collinge J. Molecular pathology of human prion disease. Acta Neuropathol 2011; 121:69 - 77; http://dx.doi.org/10.1007/s00401-010-0735-5; PMID: 20694796
  • Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012; 38:296 - 310; http://dx.doi.org/10.1111/j.1365-2990.2012.01265.x; PMID: 22394291
  • Gambetti P, Cali I, Notari S, Kong Q, Zou W-Q, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 2011; 121:79 - 90; http://dx.doi.org/10.1007/s00401-010-0761-3; PMID: 21058033
  • Bett C, Joshi-Barr S, Lucero M, Trejo M, Liberski P, Kelly JW, Masliah E, Sigurdson CJ. Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog 2012; 8:e1002522; http://dx.doi.org/10.1371/journal.ppat.1002522; PMID: 22319450
  • Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012; 11:618 - 28; http://dx.doi.org/10.1016/S1474-4422(12)70063-7; PMID: 22710755
  • Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 1990; 110:743 - 52; http://dx.doi.org/10.1083/jcb.110.3.743; PMID: 1968466
  • Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266:18217 - 23; PMID: 1680859
  • James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB, et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A 1997; 94:10086 - 91; http://dx.doi.org/10.1073/pnas.94.19.10086; PMID: 9294167
  • Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 1996; 382:180 - 2; http://dx.doi.org/10.1038/382180a0; PMID: 8700211
  • López Garcia F, Zahn R, Riek R, Wüthrich K. NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A 2000; 97:8334 - 9; http://dx.doi.org/10.1073/pnas.97.15.8334; PMID: 10899999
  • Zahn R, Liu A, Lührs T, Riek R, von Schroetter C, López García F, Billeter M, Calzolai L, Wider G, Wüthrich K. NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A 2000; 97:145 - 50; http://dx.doi.org/10.1073/pnas.97.1.145; PMID: 10618385
  • Stöhr J, Watts JC, Legname G, Oehler A, Lemus A, Nguyen H-OB, Sussman J, Wille H, DeArmond SJ, Prusiner SB, et al. Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A 2011; 108:21223 - 8; http://dx.doi.org/10.1073/pnas.1117827108; PMID: 22160704
  • Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435 - 9; http://dx.doi.org/10.1126/science.1110837; PMID: 15933194
  • Zou W-Q, Capellari S, Parchi P, Sy M-S, Gambetti P, Chen SG. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 2003; 278:40429 - 36; http://dx.doi.org/10.1074/jbc.M308550200; PMID: 12917418
  • Norstrom EM, Mastrianni JA. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation. J Biol Chem 2005; 280:27236 - 43; http://dx.doi.org/10.1074/jbc.M413441200; PMID: 15917252
  • Jobling MF, Stewart LR, White AR, McLean C, Friedhuber A, Maher F, Beyreuther K, Masters CL, Barrow CJ, Collins SJ, et al. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J Neurochem 1999; 73:1557 - 65; http://dx.doi.org/10.1046/j.1471-4159.1999.0731557.x; PMID: 10501201
  • Supattapone S, Bosque P, Muramoto T, Wille H, Aagaard C, Peretz D, Nguyen H-OB, Heinrich C, Torchia M, Safar J, et al. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell 1999; 96:869 - 78; http://dx.doi.org/10.1016/S0092-8674(00)80596-6; PMID: 10102274
  • Solomon IH, Khatri N, Biasini E, Massignan T, Huettner JE, Harris DA. An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity. J Biol Chem 2011; 286:14724 - 36; http://dx.doi.org/10.1074/jbc.M110.214973; PMID: 21385869
  • Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004; 305:673 - 6; http://dx.doi.org/10.1126/science.1100195; PMID: 15286374
  • van der Kamp MW, Daggett V. The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 2009; 22:461 - 8; http://dx.doi.org/10.1093/protein/gzp039; PMID: 19602567
  • Lloyd SE, Mead S, Collinge J. Genetics of prion diseases. Curr Opin Genet Dev 2013; 23:345 - 51; http://dx.doi.org/10.1016/j.gde.2013.02.012; PMID: 23518043
  • Beck JA, Poulter M, Campbell TA, Adamson G, Uphill JB, Guerreiro R, Jackson GS, Stevens JC, Manji H, Collinge J, et al. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 2010; 31:E1551 - 63; http://dx.doi.org/10.1002/humu.21281; PMID: 20583301
  • Giachin G, Biljan I, Ilc G, Plavec J, Legname G. Probing early misfolding events in prion protein mutants by NMR spectroscopy. Molecules 2013; 18:9451 - 76; http://dx.doi.org/10.3390/molecules18089451; PMID: 23966072
  • Liemann S, Glockshuber R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 1999; 38:3258 - 67; http://dx.doi.org/10.1021/bi982714g; PMID: 10079068
  • Swietnicki W, Petersen RB, Gambetti P, Surewicz WK. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 1998; 273:31048 - 52; http://dx.doi.org/10.1074/jbc.273.47.31048; PMID: 9813003
  • van der Kamp MW, Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol 2010; 404:732 - 48; http://dx.doi.org/10.1016/j.jmb.2010.09.060; PMID: 20932979
  • Alonso DOV, DeArmond SJ, Cohen FE, Daggett V. Mapping the early steps in the pH-induced conformational conversion of the prion protein. Proc Natl Acad Sci U S A 2001; 98:2985 - 9; http://dx.doi.org/10.1073/pnas.061555898; PMID: 11248018
  • DeMarco ML, Daggett V. From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A 2004; 101:2293 - 8; http://dx.doi.org/10.1073/pnas.0307178101; PMID: 14983003
  • Alzualde A, Indakoetxea B, Ferrer I, Moreno F, Barandiaran M, Gorostidi A, Estanga A, Ruiz I, Calero M, van Leeuwen FW, et al. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 2010; 69:789 - 800; http://dx.doi.org/10.1097/NEN.0b013e3181e85737; PMID: 20613639
  • Peoc’h K, Manivet P, Beaudry P, Attane F, Besson G, Hannequin D, Delasnerie-Lauprêtre N, Laplanche J-L. Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum Mutat 2000; 15:482; http://dx.doi.org/10.1002/(SICI)1098-1004(200005)15:5<482::AID-HUMU16>3.0.CO;2-1; PMID: 10790216
  • van der Kamp MW, Daggett V. Influence of pH on the human prion protein: insights into the early steps of misfolding. Biophys J 2010; 99:2289 - 98; http://dx.doi.org/10.1016/j.bpj.2010.07.063; PMID: 20923664
  • Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K. Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A 1998; 95:11667 - 72; http://dx.doi.org/10.1073/pnas.95.20.11667; PMID: 9751723
  • Daggett V. Alpha-sheet: The toxic conformer in amyloid diseases?. Acc Chem Res 2006; 39:594 - 602; http://dx.doi.org/10.1021/ar0500719; PMID: 16981675
  • Armen RS, DeMarco ML, Alonso DOV, Daggett V. Pauling and Corey’s alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci U S A 2004; 101:11622 - 7; http://dx.doi.org/10.1073/pnas.0401781101; PMID: 15280548
  • Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F. Neurotoxicity of a prion protein fragment. Nature 1993; 362:543 - 6; http://dx.doi.org/10.1038/362543a0; PMID: 8464494
  • Lisa S, Meli M, Cabello G, Gabizon R, Colombo G, Gasset M. The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines. Cell Mol Life Sci 2010; 67:2825 - 38; http://dx.doi.org/10.1007/s00018-010-0363-1; PMID: 20454997
  • Calzolai L, Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 2003; 278:35592 - 6; http://dx.doi.org/10.1074/jbc.M303005200; PMID: 12826672
  • DeMarco ML, Daggett V. Molecular mechanism for low pH triggered misfolding of the human prion protein. Biochemistry 2007; 46:3045 - 54; http://dx.doi.org/10.1021/bi0619066; PMID: 17315950
  • Zuegg J, Gready JE. Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions. Biochemistry 1999; 38:13862 - 76; http://dx.doi.org/10.1021/bi991469d; PMID: 10529232
  • Bamdad K, Naderi-Manesh H. Contribution of a putative salt bridge and backbone dynamics in the structural instability of human prion protein upon R208H mutation. Biochem Biophys Res Commun 2007; 364:719 - 24; http://dx.doi.org/10.1016/j.bbrc.2007.10.011; PMID: 17980350
  • Langella E, Improta R, Crescenzi O, Barone V. Assessing the acid-base and conformational properties of histidine residues in human prion protein (125-228) by means of pK(a) calculations and molecular dynamics simulations. Proteins 2006; 64:167 - 77; http://dx.doi.org/10.1002/prot.20979; PMID: 16639746
  • Watanabe Y, Inanami O, Horiuchi M, Hiraoka W, Shimoyama Y, Inagaki F, Kuwabara M. Identification of pH-sensitive regions in the mouse prion by the cysteine-scanning spin-labeling ESR technique. Biochem Biophys Res Commun 2006; 350:549 - 56; http://dx.doi.org/10.1016/j.bbrc.2006.09.082; PMID: 17022940
  • Hosszu LLP, Wells MA, Jackson GS, Jones S, Batchelor M, Clarke AR, Craven CJ, Waltho JP, Collinge J. Definable equilibrium states in the folding of human prion protein. Biochemistry 2005; 44:16649 - 57; http://dx.doi.org/10.1021/bi051277k; PMID: 16342955
  • Torrent J, Alvarez-Martinez MT, Liautard J-P, Balny C, Lange R. The role of the 132-160 region in prion protein conformational transitions. Protein Sci 2005; 14:956 - 67; http://dx.doi.org/10.1110/ps.04989405; PMID: 15772306
  • Alonso DOV, An C, Daggett V. Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein. Eng Sci 2002; 360:1165 - 78
  • Colacino S, Tiana G, Broglia RA, Colombo G. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions. Proteins 2006; 62:698 - 707; http://dx.doi.org/10.1002/prot.20804; PMID: 16432880
  • De Simone A, Zagari A, Derreumaux P. Structural and hydration properties of the partially unfolded states of the prion protein. Biophys J 2007; 93:1284 - 92; http://dx.doi.org/10.1529/biophysj.107.108613; PMID: 17483173
  • Eghiaian F, Daubenfeld T, Quenet Y, van Audenhaege M, Bouin A-P, van der Rest G, Grosclaude J, Rezaei H. Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage. Proc Natl Acad Sci U S A 2007; 104:7414 - 9; http://dx.doi.org/10.1073/pnas.0607745104; PMID: 17442756
  • Hafner-Bratkovic I, Bester R, Pristovšek P, Gaedtke L, Veranič P, Gašperšič J, Manček-Keber M, Avbelj M, Polymenidou M, Julius C, et al. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem 2011; 286:12149 - 56; http://dx.doi.org/10.1074/jbc.M110.213926; PMID: 21324909
  • Zhang Y, Qian J, Wang P-Y, Ou-Yang Z-C. Molecular dynamical simulations of point mutation occurring at the 198-th site of prion protein. J Comput Theor Nanosci 2006; 3:964 - 9; http://dx.doi.org/10.1166/jctn.2006.012
  • Zhang Y, Dai L, Iwamoto M, Ou-Yang Z. Molecular dynamics study on the conformational transition of prion induced by the point mutation: F198S. Thin Solid Films 2006; 499:224 - 8; http://dx.doi.org/10.1016/j.tsf.2005.07.008
  • Vanik DL, Surewicz WK. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. J Biol Chem 2002; 277:49065 - 70; http://dx.doi.org/10.1074/jbc.M207511200; PMID: 12372829
  • Julien O, Chatterjee S, Thiessen A, Graether SP, Sykes BD. Differential stability of the bovine prion protein upon urea unfolding. Protein Sci 2009; 18:2172 - 82; http://dx.doi.org/10.1002/pro.231; PMID: 19693935
  • Jones M, McLoughlin V, Connolly JG, Farquhar CF, MacGregor IR, Head MW. Production and characterization of a panel of monoclonal antibodies against native human cellular prion protein. Hybridoma (Larchmt) 2009; 28:13 - 20; http://dx.doi.org/10.1089/hyb.2008.0067; PMID: 19132894
  • Hart T, Hosszu LLP, Trevitt CR, Jackson GS, Waltho JP, Collinge J, Clarke AR. Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci U S A 2009; 106:5651 - 6; http://dx.doi.org/10.1073/pnas.0811457106; PMID: 19321423
  • Kachel N, Kremer W, Zahn R, Kalbitzer HR. Observation of intermediate states of the human prion protein by high pressure NMR spectroscopy. BMC Struct Biol 2006; 6:16; http://dx.doi.org/10.1186/1472-6807-6-16; PMID: 16846506
  • Abalos GC, Cruite JT, Bellon A, Hemmers S, Akagi J, Mastrianni JA, Williamson RA, Solforosi L. Identifying key components of the PrPC-PrPSc replicative interface. J Biol Chem 2008; 283:34021 - 8; http://dx.doi.org/10.1074/jbc.M804475200; PMID: 18826953
  • DeMarco ML, Silveira J, Caughey B, Daggett V. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry 2006; 45:15573 - 82; http://dx.doi.org/10.1021/bi0612723; PMID: 17176078
  • Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057 - 70; http://dx.doi.org/10.1038/emboj.2011.86; PMID: 21441896
  • Rambold AS, Müller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J. Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J 2008; 27:1974 - 84; http://dx.doi.org/10.1038/emboj.2008.122; PMID: 18566584
  • Supattapone S, Bouzamondo E, Ball HL, Wille H, Nguyen H-OB, Cohen FE, DeArmond SJ, Prusiner SB, Scott M. A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice. Mol Cell Biol 2001; 21:2608 - 16; http://dx.doi.org/10.1128/MCB.21.7.2608-2616.2001; PMID: 11259607
  • Kundu B, Maiti NR, Jones EM, Surewicz KA, Vanik DL, Surewicz WK. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc Natl Acad Sci U S A 2003; 100:12069 - 74; http://dx.doi.org/10.1073/pnas.2033281100; PMID: 14519851
  • Helmus JJ, Surewicz K, Nadaud PS, Surewicz WK, Jaroniec CP. Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc Natl Acad Sci U S A 2008; 105:6284 - 9; http://dx.doi.org/10.1073/pnas.0711716105; PMID: 18436646
  • Chen W, van der Kamp MW, Daggett V. Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations. Biochemistry 2010; 49:9874 - 81; http://dx.doi.org/10.1021/bi101449f; PMID: 20949975
  • Sigurdson CJ, Joshi-Barr S, Bett C, Winson O, Manco G, Schwarz P, Rülicke T, Nilsson KPR, Margalith I, Raeber A, et al. Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein. J Neurosci 2011; 31:13840 - 7; http://dx.doi.org/10.1523/JNEUROSCI.3504-11.2011; PMID: 21957246
  • Scouras AD, Daggett V. Disruption of the X-loop turn of the prion protein linked to scrapie resistance. Protein Eng Des Sel 2012; 25:243 - 9; http://dx.doi.org/10.1093/protein/gzs009; PMID: 22447804
  • Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157 - 65; http://dx.doi.org/10.1038/2654; PMID: 9771749
  • Nilsson KPR, Joshi-Barr S, Winson O, Sigurdson CJ. Prion strain interactions are highly selective. J Neurosci 2010; 30:12094 - 102; http://dx.doi.org/10.1523/JNEUROSCI.2417-10.2010; PMID: 20826672
  • Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, Ollesch J, Borovinskiy AL, Cohen FE, Prusiner SB, et al. Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci U S A 2009; 106:16990 - 5; http://dx.doi.org/10.1073/pnas.0909006106; PMID: 19805070
  • Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, Baskakov IV. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog 2011; 7:e1002419; http://dx.doi.org/10.1371/journal.ppat.1002419; PMID: 22144901
  • Scouras AD, Daggett V. The Dynameomics rotamer library: amino acid side chain conformations and dynamics from comprehensive molecular dynamics simulations in water. Protein Sci 2011; 20:341 - 52; http://dx.doi.org/10.1002/pro.565; PMID: 21280126
  • van der Kamp MW, Schaeffer RD, Jonsson AL, Scouras AD, Simms AM, Toofanny RD, Benson NC, Anderson PC, Merkley ED, Rysavy S, et al. Dynameomics: a comprehensive database of protein dynamics. Structure 2010; 18:423 - 35; http://dx.doi.org/10.1016/j.str.2010.01.012; PMID: 20399180
  • Beck DAC, McCully ME, Alonso DOV, Daggett V. in lucem Molecular Mechanics (ilmm). University of Washington, Seattle: 2000-2014.
  • Levitt M, Hirshberg M, Sharon R, Daggett V. Potential energy function and parameters for simulations of the molecular dynamics of proteins and nucleic acids in solution. Comput Phys Commun 1995; 91:215 - 31; http://dx.doi.org/10.1016/0010-4655(95)00049-L
  • Levitt M, Hirshberg M, Sharon R, Laidig KE, Daggett V. Calibration and testing of a water model for simulation of the molecular dynamics of proteins and nucleic acids in solution. J Phys Chem B 1997; 101:5051 - 61; http://dx.doi.org/10.1021/jp964020s
  • Beck DAC, Daggett V. Methods for molecular dynamics simulations of protein folding/unfolding in solution. Methods 2004; 34:112 - 20; http://dx.doi.org/10.1016/j.ymeth.2004.03.008; PMID: 15283920
  • Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971; 55:379 - 400; http://dx.doi.org/10.1016/0022-2836(71)90324-X; PMID: 5551392
  • Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22:2577 - 637; http://dx.doi.org/10.1002/bip.360221211; PMID: 6667333
  • Scouras AD, Daggett V. Species variation in PrPSc protofibril models. J Mater Sci 2008; 43:3625 - 37; http://dx.doi.org/10.1007/s10853-008-2578-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.